INIS
mice
100%
hemophilia
84%
gene therapy
71%
humans
71%
myoblasts
66%
alginates
64%
delivery
62%
genes
40%
proteins
40%
stem cells
37%
encapsulation
37%
human factors
33%
viability
33%
levels
32%
applications
29%
in vivo
27%
blood
22%
tissues
22%
plasma
20%
in vitro
20%
therapy
20%
growth
19%
antibodies
19%
secretion
17%
cost
17%
bones
17%
enzymes
17%
vectors
15%
diseases
15%
modifications
15%
growth hormone
14%
matrices
14%
covid-19
14%
fibroblasts
14%
genetics
14%
capsules
14%
patients
14%
polymers
13%
comparative evaluations
13%
nanoparticles
13%
animals
12%
dna
12%
transmission
12%
lysine
12%
regeneration
12%
transplants
12%
viruses
11%
fibrinogen
11%
soviet union
11%
hepatitis
11%
Keyphrases
Microcapsules
50%
Factor 9
48%
Gene Therapy
33%
Myoblast
32%
Alginate Microcapsules
30%
Recombinant
27%
Hemophilia
24%
Hemophilia B
20%
Human Factor IX (hFIX)
20%
Encapsulated Cells
17%
Recombinant Cells
13%
Somatic Cell Therapy
11%
Genetic Modification
11%
Non-autologous
11%
Therapeutic Levels
11%
Alginate
11%
Allogeneic
10%
Immune Response
10%
Growth Hormone
10%
Gene Products
10%
Immunogenicity
8%
Fibroblasts
8%
COVID-19
7%
Dwarf Mice
7%
Recombinant Gene
7%
Biocompatibility
6%
Poly-L-lysine
6%
Cell Viability
6%
Hepatitis C Virus
6%
Growth-related Genes
6%
Universal Cells
6%
Therapeutic Proteins
6%
Mesenchymal Stromal Cells
6%
Human Growth Hormone
5%
Mesenchymal Stem Cells
5%
Therapeutic Approaches
5%
Sustained Delivery
5%
Human Mesenchymal Stem Cells (hMSCs)
5%
Fibrinogen
5%
Mammalian Cells
5%
Fibronectin
5%
Microencapsulated Cells
5%
Monoclonal Antibody
5%
Transfer Approach
5%
Cell Wall Proteins
5%
Activation Peptide
5%
Human Tumor Cells
5%
Color Flow
5%
NK Cell Cytotoxicity
5%
Non-adherent
5%
